Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Protein Trees

Abstract:
Branched Molecule acts as Carrier for Multiple Proteins—A New Approach to the Production of Multivalent Drugs

Protein Trees

July 21, 2005

Molecular recognition plays an important role in biological processes. In general, it involves fairly weak interactions between individual molecular fragments. However, markedly strong bonds are occasionally observed, such as those between antibodies and their antigens. One reason for this seems to be that antigens can have multiple binding sites, to which multiple antigen-binding sites in the antibody can bind at the same time. This once again demonstrates that the whole can be more than the sum of its parts; the multiple interactions are stronger than would be expected from the corresponding individual bonds. In addition, the specificity of the molecular recognition is higher. Researchers wish to use this phenomenon, known as multivalency, for the development of pharmaceuticals and targeted-imaging agents. “The idea is to attach several pharmacologically active peptides or proteins to a scaffold in order to present the target molecule with multiple binding sites, which should increase the selectivity and strength of the binding,” explains E. W. “Bert” Meijer.

Meijer and his team of scientists from the Universities of Eindhoven and Maastricht chose to use dendrimers as scaffold molecules. Dendrimers are spherical, highly symmetrical molecules with cascading branches. As with a tree, the central trunk of the molecule holds branches, which then continue to branch out further and further. The researchers in the Netherlands thus needed to produce dendrimers with proteins attached to the tips of their branches—no easy task.

However, the researchers found a generally applicable strategy, a method called Native Chemical Ligation, by which protein fragments can selectively and spontaneously be hooked together to form “natural” peptide bonds. In order for this to work with dendrimers, the tips of the branches must be equipped with special functional groups. The proteins and peptide chains must then be attached to the required complementary fragment.

If an excess of dendrimer is then allowed to react with a low amount of protein, dendrimer molecules are formed that contain exactly one protein molecule each. Subsequently, more branches can be equipped with proteins - either the same kind or a different sort. The number of proteins attached depends on the size, form, and, of course, the number of branch tips on the dendrimer. “Our method offers access to a broad palette of precisely defined multivalent peptides and proteins,” says Meijer. “This allows for the systematic investigation of multivalent biological interactions.”

####

Author: E. W. "Bert" Meijer, Technische Universiteit Eindhoven (The Netherlands), yp.chem.tue.nl/showemp.php/176

Title: Multivalent Peptide and Protein Dendrimers Using Native Chemical Ligation

Angewandte Chemie International Edition, doi: 10.1002/anie.200500635


Media Contact:
Editorial office:
angewandte@wiley-vch.de

or David Greenberg (US)
dgreenbe@wiley.com

or Julia Lampam (UK) jlampam@wiley.co.uk

Copyright © Angewandte Chemie

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

Announcements

Leti IEDM 2016 Paper Clarifies Correlation between Endurance, Window Margin and Retention in RRAM for First Time: Paper Presented at IEDM 2016 Offers Ways to Reconcile High-cycling Requirements and Instability at High Temperatures in Resistive RAM December 6th, 2016

Tokyo Institute of Technology research: 3D solutions to energy savings in silicon power transistors December 6th, 2016

Physicists decipher electronic properties of materials in work that may change transistors December 6th, 2016

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project